June 17, 2024

ServiceNow, Inc. – Consensus ‘buy’ rating and 21.3% Upside Potential

ServiceNow, Inc. with ticker code (NOW) now have 37 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $950.00 and..

CrowdStrike Holdings, Inc. – Consensus ‘buy’ rating and 4.4% Upside Potential

CrowdStrike Holdings, Inc. with ticker code (CRWD) now have 45 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price..

Teledyne Technologies Incorporated – Consensus ‘buy’ rating and 17.9% Upside Potential

Teledyne Technologies Incorporated which can be found using ticker (TDY) have now 9 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low..

Cognizant Technology Solutions Corporation – Consensus ‘hold’ rating and 18.0% Upside Potential

Cognizant Technology Solutions Corporation with ticker code (CTSH) have now 21 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The range between the high target..

Dell Technologies Inc. – Consensus ‘buy’ rating and 15.2% Upside Potential

Dell Technologies Inc. with ticker code (DELL) now have 16 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $185.00..

Fortinet, Inc. – Consensus ‘buy’ rating and 19.2% Upside Potential

Fortinet, Inc. with ticker code (FTNT) have now 37 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target..

Lam Research Corporation – Consensus ‘buy’ rating and -3.0% Downside Potential

Lam Research Corporation with ticker code (LRCX) now have 26 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $1,200.00..

Challenger Energy CEO on Charlestown deal, new Board member, and offshore license updates (LON:CEG)

Learn about Challenger Energy Group plc's recent investment by Charlestown Energy and the structure of the deal in this exclusive interview with CEO Eytan Uliel...

Ascential Plc to host a capital markets event at Cannes Lions in Cannes, France

Discover Ascential plc's investment case at the capital markets event during Cannes Lions on June 19, 2024. CEO Philip Thomas and CFO Mandy Gradden will outline the vision for growth...

Shaftesbury Capital Plc appoints Madeleine Cosgrave as an independent Non-executive Director

Shaftesbury Capital PLC appoints Madeleine Cosgrave as Non-executive Director, bringing extensive property sector experience to the Board...

AstraZeneca’s Imfinzi plus chemotherapy approved in the US for endometrial cancer

AstraZeneca's Imfinzi gains FDA approval for endometrial cancer treatment. Results show significant benefits for patients with dMMR disease...

Hikma enhances Injectables pipeline and manufacturing capabilities with Xellia acquisition

Hikma Pharmaceuticals PLC announces agreement to acquire parts of Xellia Pharmaceuticals' US business, expanding its injectables portfolio and manufacturing capabilities...

KEFI Gold and Copper publishes Annual Report and Accounts for 2023

KEFI (AIM: KEFI) announces its audited financial results for 2023. AGM details and future projects in Ethiopia and Saudi Arabia are highlighted...

Kingfisher plc appoints Bhavesh Mistry as its new Chief Financial Officer

Kingfisher plc (LON:KGF) appoints Bhavesh Mistry as new Chief Financial Officer, succeeding Bernard Bot. Mistry brings extensive finance and retail experience to the role...

Nuformix updates on patents grants for NXP002 & NXP004

Nuformix plc (LON:NFX) announces patent updates for NXP002 and NXP004, highlighting advancements in IPF treatment and cocrystal development...

Cizzle Biotechnology CIZ1B biomarker selected as part of major study with leading US cancer centre

Cizzle Biotechnology Holdings plc announces key collaborations and advancements in the development of a proprietary test for the CIZ1B biomarker for early-stage lung cancer detection...
Search

Funds

June 17, 2024

Challenger Energy CEO on Charlestown deal, new Board member, and offshore license updates (LON:CEG)

Learn about Challenger Energy Group plc's recent investment by Charlestown Energy and the structure of the deal in this exclusive interview with CEO Eytan Uliel...

Ascential Plc to host a capital markets event at Cannes Lions in Cannes, France

Discover Ascential plc's investment case at the capital markets event during Cannes Lions on June 19, 2024. CEO Philip Thomas and CFO Mandy Gradden will outline the vision for growth. Live broadcast available...

Shaftesbury Capital Plc appoints Madeleine Cosgrave as an independent Non-executive Director

Shaftesbury Capital PLC appoints Madeleine Cosgrave as Non-executive Director, bringing extensive property sector experience to the Board...

AstraZeneca’s Imfinzi plus chemotherapy approved in the US for endometrial cancer

AstraZeneca's Imfinzi gains FDA approval for endometrial cancer treatment. Results show significant benefits for patients with dMMR disease...

Hikma enhances Injectables pipeline and manufacturing capabilities with Xellia acquisition

Hikma Pharmaceuticals PLC announces agreement to acquire parts of Xellia Pharmaceuticals' US business, expanding its injectables portfolio and manufacturing capabilities...

KEFI Gold and Copper publishes Annual Report and Accounts for 2023

KEFI (AIM: KEFI) announces its audited financial results for 2023. AGM details and future projects in Ethiopia and Saudi Arabia are highlighted...

Kingfisher plc appoints Bhavesh Mistry as its new Chief Financial Officer

Kingfisher plc (LON:KGF) appoints Bhavesh Mistry as new Chief Financial Officer, succeeding Bernard Bot. Mistry brings extensive finance and retail experience to the role...

Nuformix updates on patents grants for NXP002 & NXP004

Nuformix plc (LON:NFX) announces patent updates for NXP002 and NXP004, highlighting advancements in IPF treatment and cocrystal development...

Cizzle Biotechnology CIZ1B biomarker selected as part of major study with leading US cancer centre

Cizzle Biotechnology Holdings plc announces key collaborations and advancements in the development of a proprietary test for the CIZ1B biomarker for early-stage lung cancer detection...
Search

Funds

June 17, 2024

FTSE 100

Funds